Wealth Management Partners’s AbbVie ABBV Stock Holding History

Wealth Management Partners’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.08M	Buy	4,300 +1	+0%	+$215	0.25%	77
2026 Q1	$935K	Buy	4,299 +134	+3%	+$29.7K	0.27%	77
2025 Q4	$952K	Sell	4,165 -15	-0.4%	-$3.42K	0.27%	77
2025 Q3	$968K	Sell	4,180 -29	-0.7%	-$5.91K	0.31%	66
2025 Q2	$790K	Sell	4,209 -46	-1%	-$8.55K	0.28%	73
2025 Q1	$891K	Sell	4,255 -32	-0.7%	-$6.22K	0.41%	55
2024 Q4	$762K	Buy	4,287 +434	+11%	+$79.8K	0.33%	61
2024 Q3	$761K	Sell	3,853 -489	-11%	-$91.3K	0.35%	60
2024 Q2	$745K	Buy	4,342 +1	+0%	+$166	0.36%	54
2024 Q1	$790K	Sell	4,341 -364	-8%	-$62.7K	0.4%	53
2023 Q4	$729K	Sell	4,705 -659	-12%	-$96.1K	0.41%	51
2023 Q3	$800K	Sell	5,364 -187	-3%	-$27.5K	0.5%	44
2023 Q2	$748K	Sell	5,551 -67	-1%	-$9.82K	0.47%	47
2023 Q1	$895K	Buy	5,618 +618	+12%	+$94.5K	0.63%	36
2022 Q4	$751K	Hold	5,000	–	–	0.63%	42
2022 Q3	$631K	Buy	5,000 +1,000	+25%	+$143K	0.55%	45
2022 Q2	$641K	Hold	4,000	–	–	0.56%	43
2022 Q1	$647K	Hold	4,000	–	–	0.46%	50
2021 Q4	$540K	Buy	4,000 +680	+20%	+$80.3K	0.37%	61
2021 Q3	$358K	Sell	3,320 -20	-0.6%	-$2.29K	0.27%	77
2021 Q2	$376K	Buy	3,340 +51	+2%	+$5.74K	0.26%	78
2021 Q1	$346K	Buy	3,289 +552	+20%	+$59K	0.26%	80
2020 Q4	$298K	Buy	+2,737	New	+$263K	0.23%	90

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wealth Management Partners's ABBV Position: Q2 2026 in Review

Wealth Management Partners increased its AbbVie (ABBV) stake by 0.02% in Q2 2026, buying an estimated $215 and bringing the position to 4,300 shares worth $1.08M. The position accounts for 0.25% of the portfolio, ranked #77.

Wealth Management Partners first reported a position in ABBV in Q4 2020 and has held it in 23 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Wealth Management Partners held 4,300 shares of AbbVie worth $1.08M as of Q2 2026.
Wealth Management Partners bought 1 AbbVie share in Q2 2026, an estimated $215.
AbbVie made up 0.25% of Wealth Management Partners's portfolio in Q2 2026, its #77 holding.
Wealth Management Partners first reported a position in AbbVie in Q4 2020 and has held it in 23 quarters since.
4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Wealth Management Partners's 13F filing for Q2 2026, filed 22 Jul 2026.